In contrast to the aforementioned studies, tibolone, a selective tissue regulator of estrogen activity, has been shown to induce proliferation but not migration and invasion of GBM cell lines through the ER and to increase the expression of ERβ [44]. The gene discussed is ESR2; the disease is glioblastoma.